2026/09/04
From R&D to Scale-Up: How Shandong Juntai Supports Pharmaceutical Intermediate and Peptide-Related Projects Moving a pharmaceutical intermediate or peptide-related project from laboratory dev...
2026/07/08
In June 2026, CPHI China 2026, the highly anticipated annual grand event of the global pharmaceutical industry, concluded with great success at the Shanghai New International Expo Centre. On this gra...
2026/07/08
Shandong Juntai Pharmaceutical Expands Global Supply Capability for Pharmaceutical Intermediates and Cosmetic Active Ingredients Shandong Juntai Pharmaceutical Co., Ltd., a high-tech and specialized...
2026/02/25
Pro-Xylane (Hydroxypropyl Tetrahydropyrantriol): What Formulators Should Know Pro-Xylane is a familiar name in modern skincare, but the name itself tells only part of the story. For a for...
2026/02/25
Two Pro-Xylane Samples Both Say 99%. Are They Really the Same? Imagine receiving two Pro-Xylane quotations from different suppliers. Both list the same familiar ingredient name. Both show a pur...
2026/02/25
From Pro-Xylane to S-Grade: How Juntai Builds a More Defined Product For many Pro-Xylane products, 99% purity is already an important specification. But as formulation and sourcing teams look...
